| Confidentiality, anonymity and power relations in elite interviewing: conducting qualitative policy research in a politicised domain K Lancaster International Journal of Social Research Methodology 20 (1), 93-103, 2017 | 416 | 2017 |
| Producing the ‘problem of drugs’: A cross national-comparison of ‘recovery’discourse in two Australian and British reports K Lancaster, K Duke, A Ritter International Journal of Drug Policy 26 (7), 617-625, 2015 | 171 | 2015 |
| Illicit drugs and the media: Models of media effects for use in drug policy research K Lancaster, CE Hughes, B Spicer, F MATTHEW‐SIMMONS, P Dillon Drug and alcohol review 30 (4), 397-402, 2011 | 148 | 2011 |
| Evidence-making interventions in health: A conceptual framing T Rhodes, K Lancaster Social Science & Medicine 238, 112488, 2019 | 142 | 2019 |
| Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010 K Lancaster, A Ritter International Journal of Drug Policy 25 (1), 81-87, 2014 | 135 | 2014 |
| Qualitative interviewing S Nathan, C Newman, K Lancaster | 124 | 2019 |
| How do Australian news media depict illicit drug issues? An analysis of print media reporting across and between illicit drugs, 2003–2008 CE Hughes, K Lancaster, B Spicer International Journal of Drug Policy 22 (4), 285-291, 2011 | 120 | 2011 |
| Social construction and the evidence-based drug policy endeavour K Lancaster International Journal of Drug Policy 25 (5), 948-951, 2014 | 108 | 2014 |
| Making evidence and policy in public health emergencies: lessons from COVID-19 for adaptive evidence-making and intervention K Lancaster, T Rhodes, M Rosengarten Evidence & policy 16 (3), 477-490, 2020 | 105 | 2020 |
| The productive techniques and constitutive effects of ‘evidence-based policy’and ‘consumer participation’discourses in health policy processes K Lancaster, K Seear, C Treloar, A Ritter Social Science & Medicine 176, 60-68, 2017 | 91 | 2017 |
| Mathematical models as public troubles in COVID-19 infection control: following the numbers T Rhodes, K Lancaster Health Sociology Review 29 (2), 177-194, 2020 | 86 | 2020 |
| Laws prohibiting peer distribution of injecting equipment in Australia: A critical analysis of their effects K Lancaster, K Seear, C Treloar International Journal of Drug Policy 26 (12), 1198-1206, 2015 | 82 | 2015 |
| A model society: maths, models and expertise in viral outbreaks T Rhodes, K Lancaster, M Rosengarten Critical Public Health 30 (3), 253-256, 2020 | 78 | 2020 |
| Stigma and subjectivities: Examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs K Lancaster, L Santana, A Madden, A Ritter Drugs: Education, Prevention and Policy 22 (3), 224-231, 2015 | 71 | 2015 |
| Problems, policy and politics: making sense of Australia's ‘ice epidemic’ K Lancaster, A Ritter, H Colebatch Policy Studies 35 (2), 147-171, 2014 | 68 | 2014 |
| Public opinion and drug policy in A ustralia: Engaging the ‘affected community’ K Lancaster, A Ritter, J Stafford Drug and Alcohol Review 32 (1), 60-66, 2013 | 68 | 2013 |
| Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia B Larance, L Degenhardt, J Grebely, S Nielsen, R Bruno, P Dietze, ... Addiction 115 (7), 1295-1305, 2020 | 66 | 2020 |
| The stigmatisation of ‘ice’and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia J Chalmers, K Lancaster, C Hughes International Journal of Drug Policy 36, 15-24, 2016 | 66 | 2016 |
| Modelling the pandemic: attuning models to their contexts T Rhodes, K Lancaster, S Lees, M Parker BMJ global health 5 (6), e002914, 2020 | 65 | 2020 |
| ‘Naloxone works’: The politics of knowledge in ‘evidence-based’drug policy K Lancaster, C Treloar, A Ritter Health: 21 (3), 278-294, 2017 | 64 | 2017 |
